NZ739573A - Improved methods for the acylation of maytansinol - Google Patents

Improved methods for the acylation of maytansinol

Info

Publication number
NZ739573A
NZ739573A NZ73957313A NZ73957313A NZ739573A NZ 739573 A NZ739573 A NZ 739573A NZ 73957313 A NZ73957313 A NZ 73957313A NZ 73957313 A NZ73957313 A NZ 73957313A NZ 739573 A NZ739573 A NZ 739573A
Authority
NZ
New Zealand
Prior art keywords
maytansinol
acylation
improved methods
amino acid
reaction
Prior art date
Application number
NZ73957313A
Other languages
English (en)
Inventor
Wayne Widdison
Robert Yongxin Zhao
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of NZ739573A publication Critical patent/NZ739573A/en

Links

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R12/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
    • H01R12/50—Fixed connections
    • H01R12/51—Fixed connections for rigid printed circuits or like structures
    • H01R12/55—Fixed connections for rigid printed circuits or like structures characterised by the terminals
    • H01R12/58—Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
    • H01R12/585—Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/0201—Thermal arrangements, e.g. for cooling, heating or preventing overheating
    • H05K1/0203—Cooling of mounted components
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/11—Printed elements for providing electric connections to or between printed circuits
    • H05K1/115—Via connections; Lands around holes or via connections
    • H05K1/116—Lands, clearance holes or other lay-out details concerning the surrounding of a via
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/18—Printed circuits structurally associated with non-printed electric components
    • H05K1/181—Printed circuits structurally associated with non-printed electric components associated with surface mounted components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ73957313A 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol NZ739573A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261705731P 2012-09-26 2012-09-26
NZ706019A NZ706019A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Publications (1)

Publication Number Publication Date
NZ739573A true NZ739573A (en) 2019-11-29

Family

ID=49328648

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ73957313A NZ739573A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol
NZ706019A NZ706019A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ706019A NZ706019A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Country Status (27)

Country Link
US (9) US9012629B2 (enExample)
EP (3) EP2900676B1 (enExample)
JP (7) JP6517693B2 (enExample)
CN (2) CN108586487B (enExample)
AU (4) AU2013323572B2 (enExample)
BR (2) BR122021022582B1 (enExample)
CA (2) CA2884873C (enExample)
CY (2) CY1121415T1 (enExample)
DK (2) DK2900676T3 (enExample)
ES (2) ES2716561T3 (enExample)
HR (2) HRP20190473T1 (enExample)
HU (2) HUE043285T2 (enExample)
IL (2) IL237899A (enExample)
LT (2) LT3486248T (enExample)
MX (2) MX366701B (enExample)
MY (1) MY169250A (enExample)
NZ (2) NZ739573A (enExample)
PL (2) PL3486248T3 (enExample)
PT (2) PT2900676T (enExample)
RS (2) RS58493B1 (enExample)
RU (2) RU2648992C2 (enExample)
SG (1) SG11201501918UA (enExample)
SI (2) SI2900676T1 (enExample)
SM (2) SMT201900170T1 (enExample)
TR (1) TR201903625T4 (enExample)
WO (1) WO2014052537A1 (enExample)
ZA (1) ZA201501898B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE043285T2 (hu) * 2012-09-26 2019-08-28 Immunogen Inc Javított eljárás maytansinol acilezésére
CN105585579A (zh) * 2014-10-24 2016-05-18 南京联宁生物制药有限公司 一种化合物及其制备方法以及美登素dm1的制备方法
AU2016233227B2 (en) 2015-03-17 2020-03-12 Regeneron Pharmaceuticals, Inc. Amino acid acylation reagents and methods of using the same
JP7350313B2 (ja) 2016-12-16 2023-09-26 ブルーフィン バイオメディシン， インコーポレイテッド 抗ｃｕｂドメイン含有タンパク質１（ｃｄｃｐ１）抗体、抗体薬物コンジュゲート、およびその使用方法
PL3956332T3 (pl) 2019-04-18 2023-05-29 Indena S.P.A. Diastereoselektywny sposób wytwarzania estrów majtanzynoidowych zawierających tiol lub dwusiarczek i ich produkty pośrednie
EP4067497A4 (en) 2019-11-29 2024-03-13 MicroBiopharm Japan Co., Ltd. Method for enzymatically producing maytansinol

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151042A (en) 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質ｃ−１５００３
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
US4265814A (en) 1978-03-24 1981-05-05 Takeda Chemical Industries Matansinol 3-n-hexadecanoate
JPS5562090A (en) 1978-10-27 1980-05-10 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5566585A (en) 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164687A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS55164685A (en) 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164686A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US4309428A (en) 1979-07-30 1982-01-05 Takeda Chemical Industries, Ltd. Maytansinoids
JPS5622790A (en) * 1979-07-31 1981-03-03 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JP3054741B2 (ja) * 1989-09-29 2000-06-19 武田薬品工業株式会社 Ｔａｎ―１３１３およびそのアシル誘導体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
EP1229934B1 (en) * 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
TWI298067B (en) * 2002-01-31 2008-06-21 Daiso Co Ltd New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
PL1651162T3 (pl) * 2003-05-20 2016-04-29 Immunogen Inc Maitansynoidy w leczeniu nowotworów
CN1894259A (zh) * 2003-08-22 2007-01-10 活跃生物工艺学公司 利福霉素类似物及其应用
ES2579805T3 (es) 2004-09-23 2016-08-16 Genentech, Inc. Anticuerpos y conjugados modificados por ingeniería genética con cisteína
WO2006062779A2 (en) * 2004-12-09 2006-06-15 Centocor, Inc. Anti-integrin immunoconjugates, methods and uses
US7301019B2 (en) * 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
JP5167130B2 (ja) * 2005-08-09 2013-03-21 ミレニアム ファーマシューティカルズ， インコーポレイテッド キラルアミノ酸を有するメイタンシノールのアシル化方法
US20090082386A1 (en) * 2006-11-06 2009-03-26 Erzsebet Meszarosne Sos Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2008288289A (ja) 2007-05-16 2008-11-27 Oki Electric Ind Co Ltd 電界効果トランジスタとその製造方法
ME03479B (me) 2009-06-03 2020-01-20 Immunogen Inc Metodi konjugacije
WO2011051960A2 (en) * 2009-09-25 2011-05-05 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
ES2544608T3 (es) * 2010-11-17 2015-09-02 Genentech, Inc. Conjugados de anticuerpo y de alaninil-maitansinol
HUE043285T2 (hu) * 2012-09-26 2019-08-28 Immunogen Inc Javított eljárás maytansinol acilezésére

Also Published As

Publication number Publication date
SMT202100390T1 (it) 2021-09-14
IL253988A0 (en) 2017-10-31
CA3133906A1 (en) 2014-04-03
PL2900676T3 (pl) 2019-06-28
JP2025098242A (ja) 2025-07-01
RU2648992C2 (ru) 2018-03-29
WO2014052537A1 (en) 2014-04-03
SMT201900170T1 (it) 2019-05-10
CN104768955A (zh) 2015-07-08
CN108586487B (zh) 2021-11-05
NZ706019A (en) 2018-03-23
JP2022068367A (ja) 2022-05-09
AU2013323572B2 (en) 2017-12-07
AU2018201392B2 (en) 2020-03-12
IL253988B (en) 2019-02-28
TR201903625T4 (tr) 2019-04-22
AU2022201557A1 (en) 2022-03-31
EP3486248B1 (en) 2021-04-07
US9796731B2 (en) 2017-10-24
US9012629B2 (en) 2015-04-21
HUE043285T2 (hu) 2019-08-28
SI3486248T1 (sl) 2021-10-29
CA2884873A1 (en) 2014-04-03
ES2716561T3 (es) 2019-06-13
LT2900676T (lt) 2019-03-25
US20140142297A1 (en) 2014-05-22
MY169250A (en) 2019-03-19
DK2900676T3 (en) 2019-04-08
HK1212341A1 (en) 2016-06-10
JP2016500657A (ja) 2016-01-14
AU2013323572A1 (en) 2015-04-02
ES2880754T3 (es) 2021-11-25
JP6735000B1 (ja) 2020-08-05
EP2900676A1 (en) 2015-08-05
JP2024010055A (ja) 2024-01-23
US10461449B2 (en) 2019-10-29
BR112015006505B1 (pt) 2022-03-15
AU2020203823A1 (en) 2020-07-02
MX366701B (es) 2019-07-22
ZA201501898B (en) 2019-06-26
MX390615B (es) 2025-03-20
PT2900676T (pt) 2019-03-29
IL237899A (en) 2017-08-31
CY1121415T1 (el) 2020-05-29
HUE055443T2 (hu) 2021-11-29
EP2900676B1 (en) 2018-12-19
SG11201501918UA (en) 2015-05-28
US20200153130A1 (en) 2020-05-14
PT3486248T (pt) 2021-07-12
BR112015006505A2 (pt) 2017-07-04
HRP20190473T1 (hr) 2019-05-03
JP2018109044A (ja) 2018-07-12
AU2018201392A1 (en) 2018-03-15
CN104768955B (zh) 2018-04-27
RU2765072C2 (ru) 2022-01-25
RS58493B1 (sr) 2019-04-30
MX2019008652A (es) 2019-09-13
US10944190B2 (en) 2021-03-09
CY1124337T1 (el) 2022-07-22
SI2900676T1 (sl) 2019-04-30
HRP20211030T1 (hr) 2021-10-01
JP2020117527A (ja) 2020-08-06
EP3486248A1 (en) 2019-05-22
US10100062B2 (en) 2018-10-16
BR122021022582B1 (pt) 2023-01-10
EP3904358A1 (en) 2021-11-03
US20190013604A1 (en) 2019-01-10
JP6517693B2 (ja) 2019-05-22
LT3486248T (lt) 2021-08-25
RU2015111635A (ru) 2016-11-20
AU2020203823B2 (en) 2021-12-09
US20150191488A1 (en) 2015-07-09
CA2884873C (en) 2021-11-23
CA3133906C (en) 2023-05-02
RS62075B1 (sr) 2021-07-30
US20240313444A1 (en) 2024-09-19
US20240145953A1 (en) 2024-05-02
US20180099980A1 (en) 2018-04-12
MX2015003745A (es) 2015-06-24
RU2018109295A3 (enExample) 2021-06-24
JP2020180150A (ja) 2020-11-05
DK3486248T3 (da) 2021-07-12
RU2018109295A (ru) 2019-02-26
US9469655B2 (en) 2016-10-18
PL3486248T3 (pl) 2021-10-25
US20250007192A1 (en) 2025-01-02
US20170137440A1 (en) 2017-05-18
CN108586487A (zh) 2018-09-28

Similar Documents

Publication Publication Date Title
HK1221472A1 (zh) 用於增加蛋白质的焦谷氨酸形成的方法
WO2013060867A3 (en) Production of heterodimeric proteins
NZ739573A (en) Improved methods for the acylation of maytansinol
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
PH12014502764A1 (en) Method
SG195111A1 (en) Process for preparing methacrylic acid
WO2014041565A3 (en) Improved process for preparation of vilanterol and intermediates thereof
IN2014CN03197A (enExample)
IN2014CN04470A (enExample)
PH12013500554A1 (en) Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation
MX371441B (es) Proyectil frangible y metodo para hacerlo.
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
EP3178804A4 (en) Method for producing high-efficiency methanol capable of reducing emission of carbon dioxide
EP3048172A4 (en) Method for producing l-amino acid from seaweed-derived biomass
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
SI3262024T1 (sl) Postopek za izdelavo aminokislin iz prekurzorjev, dobljenih z anaerobno fermentacijo iz fermentabilne biomase
IL222360A0 (en) Method of vaccination
SG11201505171PA (en) Method for improving yield of enzymatic preparation of biodiesel from greases
IN2014MN01621A (enExample)
EP3098313A4 (en) Method for producing rare fatty acid using novel enzyme, and novel rare fatty acid
MX349985B (es) Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi.
WO2014008204A3 (en) Structures of proteasome inhibitors and methods for synthesizing and use thereof
MX342471B (es) Procedimiento de preparacion de un ester de acido carboxilico.
MX345822B (es) Separacion de enantiomeros derivados de triazina usando acido tartarico.
EP2886548A4 (en) PROCESS FOR THE PREPARATION OF A BORINIC ACID DERIVATIVE AND NEW BORIC ACID DERIVATIVE

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2021 BY COMPUTER PACKAGES INC

Effective date: 20200901

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2022 BY COMPUTER PACKAGES INC

Effective date: 20210830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2023 BY COMPUTER PACKAGES INC

Effective date: 20220830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2024 BY COMPUTER PACKAGES INC

Effective date: 20230830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2025 BY COMPUTER PACKAGES INC

Effective date: 20240830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2026 BY THOMSON REUTERS

Effective date: 20250801